FDA Extends PDUFA Date For Polyphenon(R) E Ointment To October 31, 2006
Mon, 03 Jul 2006 06:00 AM EST
... BRADLEYPHARMACEUTICALS, INC. (NYSE: BDY) announced it has been advised by MediGeneAG (Frankfurt, TecDAX: MDG), its licensor of Polyphenon(R) E Ointment, thatthe FDA has extended the deadline for the completion of its review of thisproduct for treatment of external genital warts to October 31, 2006. The PDUFA date was originally July 28, 2006. [click link for full article] ...
Related Topics
- Tacrolimus ointment
- Polymyxin B, Bacitracin, and Neomycin Ophthalmic Ointment
- Pregnancy
- Date Rape Drugs
- Nitroglycerin Ointment
- Lidocaine Ointment
- Tobramycin Ophthalmic Ointment
- Zaleplon
- Polymyxin B, Bacitracin, and Neomycin
- Acyclovir Cream or Ointment
- Mupirocin
- Erythromycin Ophthalmic Ointment
- Mammography
- Calcipotriene Skin Cream or Ointment
- Betamethasone
- Clobetasol
- Carcinogens
- Collagenase Ointment
- Tobramycin and Dexamethasone Ophthalmic
- Mometasone Furoate

Not Signed In -

